Sanofi exec tells biotechs not to scrimp on clinical trial design
At a time when the biotech sector has been struggling with a lack of investment, some companies have had to…
News
Viralgen and Trogenix to progress gene therapy for glioblastoma
VC firm Vivo Capital outlays $740m for biotech investment
BioVaxys and Sona partner to develop cancer therapeutics
ARS Pharma’s epinephrine nasal spray 1mg now available in US
FDA plans to expand unannounced inspections of foreign drug plants
European biotechs must understand US culture while seeking funding
FDA grants RMAT status to Opus Genetics’ OPGx-LCA5 gene therapy
